Liquid Biopsy as an Adjunct to Lung Screening Imaging

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Current lung cancer screening protocols use low-dose computed tomography scans in selected high-risk individuals. Unfortunately, utilization is low, and the rate of false-positive screens is high. Peripheral biomarkers carry meaningful promise in diagnosing and monitoring cancer with added potential advantages reducing invasive procedures and improving turnaround time. Herein, the use of such blood-based assays is considered as an adjunct to further utilization and accuracy of lung cancer screening.

Original languageEnglish (US)
Pages (from-to)411-419
Number of pages9
JournalThoracic surgery clinics
Volume33
Issue number4
DOIs
StatePublished - Nov 1 2023

Keywords

  • Disease monitoring
  • Liquid biopsy
  • Low-dose computed tomography scan
  • Lung cancer screening

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Liquid Biopsy as an Adjunct to Lung Screening Imaging'. Together they form a unique fingerprint.

Cite this